JWK 006 - Chengdu Jinweike Biotechnology
Alternative Names: JWK-006 - Chengdu Jinweike BiotechnologyLatest Information Update: 26 Apr 2024
At a glance
- Originator Chengdu Jinweike Biotechnology
- Class Eye disorder therapies; Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Eye disorders
Most Recent Events
- 11 Apr 2024 Preclinical trials in Eye disorders in China (Parenteral), prior to April 2024 (Chengdu Jinweike Biotechnology pipeline, April 2024)